Tonix Pharmaceuticals Holding (TNXP) Revenue (2022 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Revenue of $6.9 million for Q1 2026, up 183.16% year-over-year from $2.4 million in Q1 2025, and up 27.61% quarter-over-quarter from $5.4 million in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Revenue (2022 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Revenue history runs 5 years deep, the most recent figure standing at $6.9 million for Q1 2026.
- In Q1 2026, Revenue rose 183.16% year-over-year to $6.9 million; the TTM figure through Mar 2026 stood at $17.6 million (up 74.84% YoY), while the FY2025 annual figure was $13.1 million, up 29.85% from the prior year.
- Revenue for Q1 2026 stood at $6.9 million, up from $5.4 million in the prior quarter.
- The five-year high for Revenue was $6.9 million in Q1 2026, with the low at $2.0 million in Q2 2025.
- The 5-year median for Revenue is $3.4 million (2023), against an average of $3.6 million.
- The sharpest annual moves came in 2024 and 2026: Revenue plunged 37.7% in 2024, then soared 183.16% in 2026.
- Tonix Pharmaceuticals Holding's Revenue stood at $3.6 million in 2022, then grew by 3.96% to $3.8 million in 2023, then slumped by 31.68% to $2.6 million in 2024, then surged by 108.75% to $5.4 million in 2025, then rose by 27.61% to $6.9 million in 2026.
- Business Quant data shows TNXP's Revenue at $6.9 million in Q1 2026, $5.4 million in Q4 2025, and $3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | 13.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.54 Mn |
| Mar 31, 2026 | 6.88 Mn |
| Dec 31, 2025 | 5.39 Mn |
| Sep 30, 2025 | 3.29 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.43 Mn |
| Dec 31, 2024 | 2.58 Mn |
| Sep 30, 2024 | 2.82 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Mar 31, 2024 | 2.48 Mn |
| Dec 31, 2023 | 3.78 Mn |
| Sep 30, 2023 | 3.99 Mn |
| Jun 30, 2023 | 3.54 Mn |
| Sep 30, 2022 | 3.64 Mn |
| Jun 30, 2022 | 4.74 Mn |